Thomas John Semrad
Thomas John Semrad publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations and Cancer Treatment and Pharmacology.
- World rank
- #2,419,944 of 7,710,434 ranked researchers
- Rank in United States
- #716,900 of 1,627,098
- Works
- 77
- Citations
- 1.4k
- Citations per work
- 18.5
What does Thomas John Semrad research?
Thomas John Semrad's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4457.5%
- Medicine4457.5%
- Everything else2228.0%
- Life Sciences1114.5%
- 1Oncology32% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Cancer Research8% of their works
- 4Surgery6% of their works
- 5Molecular Biology6% of their works
- 6Endocrinology, Diabetes and Metabolism4% of their works
Research topics
Which keywords describe Thomas John Semrad's research?
The keywords of their largest research topics: Chemotherapy, Targeted Therapy, Cetuximab, KRAS Mutations, ALK Inhibitors, EGFR Mutations, Immunotherapy and Tumor Microenvironment.
- Surgical Complications
- Microtubules
- Warburg Effect
- Mutational Signatures
- HIF-1
- Taxanes
- Tumor Microenvironment
- EGFR Mutations
- KRAS Mutations
- Targeted Therapy
- Chemotherapy
- Cetuximab
- ALK Inhibitors
- Immunotherapy
- Chemotherapy-Induced Peripheral Neuropathy
- Cancer Genomics
- Metastatic
- Renal Cell Carcinoma
- Cell Division
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Chemotherapy212 topics
- Targeted Therapy212 topics
- Cetuximab151 topic
- KRAS Mutations151 topic
- ALK Inhibitors141 topic
- EGFR Mutations141 topic
- Immunotherapy132 topics
- Tumor Microenvironment132 topics
- Chemotherapy-Induced Peripheral Neuropathy101 topic
- Taxanes101 topic
- Cancer Genomics71 topic
- HIF-171 topic
- Metastatic71 topic
- Mutational Signatures71 topic
- Renal Cell Carcinoma71 topic
- Warburg Effect71 topic
- Cell Division61 topic
- Microtubules61 topic
- Pancreatic Cancer61 topic
- Surgical Complications61 topic
Where does Thomas John Semrad work?
Thomas John Semrad's main affiliation in the publication record is University of California, Davis, United States.
How many publications and citations does Thomas John Semrad have?
OpenAlex counts 77 works and 1,424 citations for Thomas John Semrad, an h-index of 17, ranking #2,419,944 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas John Semrad. Posts are plain text and can be reported.